• 1
  • 2
  • 3
  • Default
  • Title
  • Date
  • Random


  • The largest inventory of fine chemical, standard and pharma grade cyclodextrins derivatives from mg to kg scale, maltooligormes, fluorescent tagged cyclodextrins, single isomers, polymers and special HPLC columns for their qualification.
    Details


  • Commercially available USP N.F. grade Betadex Sulfobutyl Ether Sodium manufactured under cGMP conditions. We also provide corresponding development services and reference materials for the qualification.
    Details


  • Every possible cyclodextrin-related service including custom GMP manufacturing of cyclodextrins, formulation development, custom synthesis of cyclodextrins, related analytical services and
    many more...
    Details

CycloLab

The world's only all-round CYCLODEXTRIN BIOTECH company

CycloLab Ltd. started its life and operated as a small R&D company for over 25 years. Recent changes in the world market and economy revealed the need for a change in the company’s business portfolio. Hence we have decided to share the resources between R&D activity and establishment of manufacturing facilities that enable the production of cyclodextrins in larger scale and under GMP circumstances.

To maintain and strengthen our position in the market, CycloLab dedicates special attention to invention and developing patentable technologies. This attitude is well highlighted by the over 130 patents filed by the company so far.

CycloLab committed its operations to serve the pharmaceutical industry by participating in early phase drug development studies (feasibility, formulation optimization, bioequivalence, etc) analysis and GMP manufacturing of various cyclodextrin derivatives to be applied as excipients.

News

  • 31-03-2015
    It is a sorrow obligation for us to inform the visitors of our website on the death of Juan J. Torres-Labandeira (52), professor of the University of Santiago de Compostela, a world-wide acknowledged researcher. He had over 100 publications (including conference presentations) on cyclodextrins according to the Cyclodextrin News Database. He studied the drug complexes with hydroxypropyl...
  • 27-02-2015
    The National Institute of Health (NIH) gave a press release on the agreement with the biotechnology company Vtesse Inc., of Gaithersburg, Maryland, on joint development of treatments for Niemann-Pick disease type C (NPC) and other lysosomal storage disorders. Vtesse is a rare disease company spun-off from Cydan Development, Inc., focusing on developing drugs for Niemann-Pick Disease Type C (NPC)...
  • 30-01-2015
    Researchers from the National Institutes of Health have entered into an agreement with biotechnology company Vtesse, Inc., of Gaithersburg, Maryland, to develop treatments for Niemann-Pick disease type C (NPC) and other lysosomal storage disorders. Researchers at the National Center for Advancing Translational Sciences (NCATS) and the Eunice Kennedy Shriver National Institute of Child Health and...
  • 30-01-2015
    These joint conferences will be in Kumamoto, Japan in May 14-16, 2015. Abstract submission date and deadline for early registration is March 1. The preliminary scientific program of invited lectures is already online. Link
  • More news

Events

Contact

CycloLab Cyclodextrin Research and Development Laboratory Ltd.

Location: Illatos út 7, Budapest, Hungary, H-1097

Mail address: Budapest, P.O.Box 435, H-1525 Hungary

Phone: 0036-1-347-6060 or -6070           Fax: 0036-1-347-6068

E-mail: cyclolab@cyclolab.hu

Registered by the Metropolitan Court as court of registration under No. Cg. 01-09-162381

VAT No.: HU 10678970